NASDAQ
Igene Biotechnology, Inc. (IGNE) has a revenue compound annual growth rate of 53.56% over 5 years and 71.36% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.